Evidence map›Paper›PMID 27862968›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2017

The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions.

P Bruneval, A Angelini, D Miller, L Potena, A Loupy, A Zeevi, E F Reed, D Dragun, N Reinsmoen, R N Smith and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. The diagnostic role of PD-1Journal of clinical laboratory analysis · 2022
    Article
  7. Article
  8. Failing Heart Transplants and Rejection-A Cellular Perspective.Journal of cardiovascular development and disease · 2021
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Immune Cell Profiling and Risk Stratification: Cast a Wider Net.JACC. Basic to translational science · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 15 institutions in 5 countries.

P BrunevalParis Translational Research Center for Organ Transplantation & Department of Pathology, Hôpital Européen Georges Pompidou, Université Paris Descartes Médecine, Paris, France.
A AngeliniDepartment of Cardiac Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy.
D MillerIntermountain Medical Center, University of Utah, Salt Lake City, UT.
L PotenaHeart and Lung Transplant Program, University of Bologna, Academic Hospital S, Orsola-Malpighi, Italy.
A LoupyParis Translational Research Center for Organ Transplantation INSERM U970, Necker Hospital University Paris Descartes, Paris, France.
A ZeeviUniversity of Pittsburgh Medical Center, Pittsburgh, PA.
E F ReedDepartment of Pathology and Laboratory Medicine, University of California, Los Angeles, CA.
D DragunBerlin Institute of Health and Department of Nephrology and Critical Care Medicine, Charité Universitätsmedizin, Berlin, Germany.
N ReinsmoenCedars-Sinai Medical Center, Los Angeles, CA.
R N SmithPathology Department, Massachusetts General Hospital, Boston, MA.
L WestAlberta Transplant Institute and University of Alberta, Edmonton, Canada.
S TebuttCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
T ThumIFB, Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
M HaasDepartment of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
M MengelDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
P ReveloIntermountain Medical Center, University of Utah, Salt Lake City, UT.
M FedrigoDepartment of Cardiac Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy.
J P Duong Van HuyenParis Translational Research Center for Organ Transplantation INSERM U970, Necker Hospital University Paris Descartes, Paris, France.
G J BerryDepartment of Pathology, Stanford University, Stanford, CA.
Cedars-Sinai Medical Center · USUniversity of Alberta · CAUniversity of Padua · ITUniversity of Utah · USBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEDélégation Paris 5 · FRHôpital Européen Georges-Pompidou · FRMassachusetts General Hospital · USMedizinische Hochschule Hannover · DEPoliclinico S.Orsola-Malpighi · ITStanford University · USSt. Paul's Hospital · CAUniversité Paris Cité · FRUniversity of California, Los Angeles · USUniversity of Pittsburgh Medical Center · US

Funding

CIHR
6 · The paper itself

Abstract

The 13th Banff Conference on Allograft Pathology was held in Vancouver, British Columbia, Canada from October 5 to 10, 2015. The cardiac session was devoted to current diagnostic issues in heart transplantation with a focus on antibody-mediated rejection (AMR) and small vessel arteriopathy. Specific topics included the strengths and limitations of the current rejection grading system, the central role of microvascular injury in AMR and approaches to semiquantitative assessment of histopathologic and immunophenotypic indicators, the role of AMR in the development of cardiac allograft vasculopathy, the important role of serologic antibody detection in the management of transplant recipients, and the potential application of new molecular approaches to the elucidation of the pathophysiology of AMR and potential for improving the current diagnostic system. Herein we summarize the key points from the presentations, the comprehensive, open and wide-ranging multidisciplinary discussion that was generated, and considerations for future endeavors.

Indexed as

Graft RejectionHumansIsoantibodiesOrgan TransplantationPractice Guidelines as TopicResearch ReportTransplantation, HomologousIsoantibodiesclinical research/practiceheart transplantation/cardiologyrejectionrejection: antibody-mediated (ABMR)rejection: subclinicaltranslational research/science

Identifiers

PMID27862968
PMCPMC5363364
OpenAlexW2556622352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.